Sven Engel
CEO, CIO & Founder
AIFOD Senior Fellow
AIFN Ambassador
Sven Engel is a biotech entrepreneur, clinical research executive and technology innovator with more than 30 years of international experience across the full pharmaceutical and biotechnology value chain — from preclinical research and translational development to global clinical execution, regulatory approval and market access.
As Founder and CEO of SynapCon, he focuses on value creation through structured, compliant and scalable clinical infrastructures. By integrating molecular biotechnology, global trial operations and advanced software architecture, he builds AI-enabled platforms designed to reduce development risk, accelerate timelines and enhance regulatory robustness.
His track record spans Phase I–IV programmes, rare diseases and international regulatory environments, combining scientific depth with operational discipline and entrepreneurial execution to translate innovation into measurable market impact.
International Leadership
& Engagement
 AIFOD Reception, Geneva – with Founder Tianze Zhang |  POLITICO “Standortfaktor Innovation”, Axel Springer Berlin – with Priscilla Schelp and industry representatives. |
|---|---|
 AIFOD Panel Discussion, Vienna (UN Office) – Q&A on medical deployment and responsible data use in developing countries. |  Best of Technology Awards, Munich (WirtschaftsWoche) – Excellence in digital clinical research solutions. |
 AIFOD Reception, Geneva – with Bernardo Cartoni (Chair, AIFOD Drafting Committee). |  IHK Frankfurt – Exchange with regulatory representatives from Côte d’Ivoire on healthcare and innovation collaboration |